SOLARA ACTIVE PHARMA SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 532.6 INR | +0.95% |
|
-8.04% | +47.49% |
| 04-08 | Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director | CI |
| 03-26 | Solara Active Pharma Gets Board Nod to Sell 100% Stake in SeQuent Penems | MT |
Quotes 5-day view
Delayed Quote NSE India S.E.| 25/04/2024 | 26/04/2024 | 29/04/2024 | 30/04/2024 | |
|---|---|---|---|---|
| Last | 560.8 ₹ | 542.35 ₹ | 527.65 ₹ | 532.65 ₹ |
| Volume | 287 023 | 200 663 | 169 922 | 192 385 |
| Change | +1.67% | -3.29% | -2.71% | +0.95% |
| Opening | 552.00 | 562.05 | 544.45 | 528.40 |
| High | 572.00 | 564.00 | 562.95 | 547.00 |
| Low | 545.00 | 535.25 | 525.55 | 527.65 |
Performance
| 1 day | +0.95% | ||
| 1 week | -8.04% | ||
| Current month | +43.59% | ||
| 1 month | +43.59% | ||
| 3 months | +35.64% | ||
| 6 months | +72.35% | ||
| Current year | +47.49% | ||
| 1 year | +41.47% | ||
| 3 years | -64.55% | ||
| 5 years | +34.51% |
Volumes
marketsDaily volume
192 385
Estimated daily volume
192 385
Avg. Volume 20 sessions
1 345 538
Daily volume ratio
0.14
Avg. Volume 20 sessions INR
716 700 815.70
Avg. Volume 20 sessions USD
8 588 225.87
Record volume 1
6 454 379
Record volume 2
4 991 668
Record volume 3
4 226 225
Capital turnover ratio
0.04
Float rotation
0.09
Basic data
Capitalization (INR)
18 993 989 402
Capitalization (USD)
227 604 975
Net sales (INR)
14 438 100 000
Net sales (USD)
173 011 752
Number of employees
2 361
Sales / Employee (INR)
6 115 248
Sales / Employee (USD)
73 279
Free-Float
43 %
Free-Float capitalization (INR)
8 167 085 752
Free-Float capitalization (USD)
97 866 189
Average Daily Capital Traded
3.77%
Highs and lows
1 week
525.55
572.00
1 month
375.00606.40
Current year
350.00606.40
1 year
286.00606.40
3 years
286.001 859.95
5 years
273.001 859.95
10 years
134.501 859.95
Indicators
Moving average 5 days
546.00
Moving average 20 days
463.53
Moving average 50 days
433.92
Moving average 100 days
405.20
Price spread / (MMA5)
+2.51%
Price spread / (MMA20)
-12.98%
Price spread / (MMA50)
-18.54%
Price spread / (MMA100)
-23.93%
STIM
RSI 9 days
61.34
RSI 14 days
62.17
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.95% | -8.04% | +47.49% | +41.47% | 228M | ||
| +5.95% | +4.75% | +34.00% | +92.48% | 664B | ||
| +2.01% | +3.12% | +29.29% | +60.52% | 567B | ||
| -1.52% | -3.32% | -7.75% | -11.62% | 354B | ||
| -0.69% | +1.84% | +18.53% | +11.07% | 330B | ||
| +0.69% | -4.07% | +4.95% | +5.81% | 286B | ||
| +0.32% | +7.22% | +13.79% | +2.69% | 234B | ||
| +0.20% | +1.93% | +4.93% | -2.28% | 199B | ||
| -0.27% | -2.30% | -9.78% | -21.31% | 196B | ||
| -0.88% | +0.15% | -4.89% | +14.27% | 148B | ||
| -0.08% | -2.66% | -11.01% | -34.66% | 145B | ||
| +1.35% | +5.57% | +3.70% | -6.92% | 123B | ||
| +0.18% | +2.04% | +15.36% | +16.10% | 85.64B | ||
| -1.12% | -2.73% | -19.52% | -20.69% | 82.23B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| +7.07% | +15.78% | +38.53% | +15.43% | 61.31B | ||
| Average | +0.88% | +0.48% | +10.51% | +10.82% | ||
| Weighted average by Cap. | +1.40% | +0.75% | +13.37% | +25.84% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
bb0c1fbe2e0d4d5ca.UATeT18PSfYal2HAHjU0gGMBcc1ZFjEtdF1j0XASPsE.YX6UKz1aOLtr21Gvaldc2jVxFvgLTnxrJCoy4CdEW60mQJU5GEc5rnDjJA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:25:09 | 532.6 | 8 | 183,646 |
| 11:19:32 | 532.6 | 2 | 183,638 |
| 11:18:45 | 532.6 | 8 | 183,636 |
| 11:15:36 | 532.6 | 150 | 183,628 |
| 11:12:24 | 532.6 | 2 | 183,478 |
| 11:10:03 | 532.6 | 10 | 183,476 |
| 11:00:04 | 530 | 8 | 183,466 |
| 10:59:59 | 530 | 205 | 183,458 |
Monthly variations
Annual change
| 2024 | +47.49% | ||
| 2023 | -16.05% | ||
| 2022 | -57.78% | ||
| 2021 | -14.48% | ||
| 2020 | +174.05% | ||
| 2019 | +40.17% | ||
| 2018 | +23.22% |
- Stock Market
- Equities
- SOLARA Stock
- Quotes Solara Active Pharma Sciences Limited
